Lateral and axial measurement differences between spectral-domain optical coherence tomography systems

Journal of Biomedical Optics

Volumn 19, Issue 1, 2014, Pages

  Folgar, Francisco A ^a   Yuan, Eric L ^a   Farsiu, Sina ^a,b   Toth, Cynthia A ^a,b  

^a DUKE UNIVERSITY   (United States)

^b Duke University   (United States)

Author keywords

Fourier domain optical coherence tomography; Image acquisition; Imaging systems; Ophthalmology; Spectral domain optical coherence tomography

Indexed keywords

CLINICAL STUDY; CONVERSION FACTOR; FOURIER DOMAIN OPTICAL COHERENCE TOMOGRAPHY; MANUAL MEASUREMENTS; NORMALIZED VALUES; PATIENT CARE; REPRODUCIBILITIES; SPECTRAL-DOMAIN OPTICAL COHERENCE TOMOGRAPHY;

IMAGE ACQUISITION; IMAGING SYSTEMS; INSTRUMENTS; MANUFACTURE; OPHTHALMOLOGY; THICKNESS MEASUREMENT;

MEASUREMENTS;

ARTICLE; AUTOMATION; COMPUTER PROGRAM; EQUIPMENT; EQUIPMENT DESIGN; EYE; HUMAN; IMAGE QUALITY; METHODOLOGY; OPTICAL COHERENCE TOMOGRAPHY; OPTICS; PATHOLOGY; RADIATION SCATTERING; REPRODUCIBILITY; RETINA; RETINA FOVEA;

AUTOMATION; EQUIPMENT DESIGN; EYE; FOVEA CENTRALIS; HUMANS; OPTICS AND PHOTONICS; PHANTOMS, IMAGING; REPRODUCIBILITY OF RESULTS; RETINA; SCATTERING, RADIATION; SOFTWARE; TOMOGRAPHY, OPTICAL COHERENCE;

EID: 84897783669     PISSN: 10833668     EISSN: 15602281     Source Type: Journal    
DOI: 10.1117/1.JBO.19.1.016014     Document Type: Article

References (27)

1. D. Huang et al., "Optical coherence tomography," Science 254(5035), 1178-1181 (1991). (Pubitemid 21917444)
2. U. Chakravarthy et al., "Ranibizumab versus bevacizumab to treat neovascular age-related macular degeneration: one-year findings from the IVAN randomized trial," Ophthalmology 119(7), 1399-1411 (2012).
3. D. F. Martin et al., "Ranibizumab and bevacizumab for treatment of neovascular age-related macular degeneration: two-year results," Ophthalmology 119(7), 1388-1398 (2012).
4. Q. D. Nguyen et al., "Ranibizumab for diabetic macular edema: results from 2 phase III trials: RISE and RIDE," Ophthalmology 119(4), 789-801 (2012).
5. R. S. Maldonado et al., "Spectral-domain optical coherence tomographic assessment of severity of cystoid macular edema in retinopathy of prematurity," Arch. Ophthalmol. 130(5), 569-578 (2012).
6. S. Farsiu et al., "Quantitative classification of eyes with and without intermediate age-related macular degeneration utilizing optical coherence tomography," Ophthalmology 121(1), 162-172 (2014).
7. I. C. Han and G. J. Jaffe, "Comparison of spectral- and time-domain optical coherence tomography for retinal thickness measurements in healthy and diseased eyes," Am. J. Ophthalmol. 147(5), 847-858 (2009).
8. U. E. Wolf-Schnurrbusch et al., "Macular thickness measurements in healthy eyes using six different optical coherence tomography instruments," Invest. Ophthalmol. Vis. Sci. 50(7), 3432-3437 (2009).
9. A. C. Sull et al., "Comparison of spectral/Fourier domain optical coherence tomography instruments for assessment of normal macular thickness," Retina 30(2), 235-245 (2010).
10. L. Pierro et al., "Macular thickness interoperator and intraoperator reproducibility in healthy eyes using 7 optical coherence tomography instruments," Am. J. Ophthalmol. 150(2), 199-204 (2010).
11. S. R. Sadda et al., "Impact of scanning density on measurements from spectral domain optical coherence tomography," Invest. Ophthalmol. Vis. Sci. 51(2), 1071-1078 (2010).
12. D. Odell et al., "Assessing errors inherent in OCT-derived macular thickness maps," J. Ophthalmol. 2011, 692574 (2011).
13. S. Hagen et al., "Reproducibility and comparison of retinal thickness and volume measurements in normal eyes determined with two different Cirrus OCT scanning protocols," Retina 31(1), 41-47 (2011).
14. R. S. Maldonado et al., "Optimizing hand-held spectral domain optical coherence tomography imaging for neonates, infants, and children," Invest. Ophthalmol. Vis. Sci. 51(5), 2678-2685 (2010).
15. I. Krebs et al., "Repeatability and reproducibility of retinal thickness measurements by optical coherence tomography in age-related macular degeneration," Ophthalmology 117(8), 1577-1584 (2010).
16. Y. Barkana et al., "Inter-device variability of the Stratus optical coherence tomography," Am. J. Ophthalmol. 147(2), 260-266 (2009).
17. L. A. Paunescu et al., "Reproducibility of nerve fiber thickness, macular thickness, and optic nerve head measurements using Stratus OCT," Invest. Ophthalmol. Vis. Sci. 45(6), 1716-1724 (2004). (Pubitemid 38868963)
18. R. de Kinkelder et al., "Comparison of retinal nerve fiber layer thickness measurements by spectral-domain optical coherence tomography systems using a phantom eye model," J. Biophotonics 6(4), 314-320 (2013).
19. R. J. Zawadzki et al., "Towards building an anatomically correct solid eye model with volumetric representation of retinal morphology," Proc. SPIE 7550, 75502F (2010).
20. R. S. Maldonado et al., "Dynamics of human foveal development after premature birth," Ophthalmology 118(12), 2315-2325 (2011).
21. A. M. Dubis et al., "Evaluation of normal human foveal development using optical coherence tomography and histologic examination," Arch. Ophthalmol. 130(10), 1291-1300 (2012).
22. L. Vajzovic et al., "Maturation of the human fovea: correlation of spectral- domain optical coherence tomography findings with histology," Am. J. Ophthalmol. 154(5), 779-789 (2012).
23. M. D. Fischer et al., "Noninvasive, in vivo assessment of mouse retinal structure using optical coherence tomography," PLoS One 4(10), 7507 (2009).
24. T. J. Bailey et al., "Spectral-domain optical coherence tomography as a noninvasive method to assess damaged and regenerating adult zebrafish retinas," Invest. Ophthalmol. Vis. Sci. 53(6), 3126-3138 (2012).
25. M. L. Gabriele et al., "Reproducibility of spectral-domain optical coherence tomography total retinal thickness measurements in mice," Invest. Ophthalmol. Vis. Sci. 51(12), 6519-6523 (2010).
26. J. N. Leuschen et al., "Spectral-domain optical coherence tomography characteristics of intermediate age-related macular degeneration," Ophthalmology 120(1), 140-150 (2013).
27. L. Fang et al., "Fast acquisition and reconstruction of optical coherence tomography images via sparse representation," IEEE Trans. Med. Imaging 32(11), 2034-2049 (2013).